Similar articles

• A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma.

  Law V, Chen Z, Vena F, Smalley I, Macaulay R, Evernden BR, Tran N, Pina Y, Puskas J, Caceres G, Bayle S, Johnson J, Liu JKC, Etame A, Vogelbaum M, Rodriguez P, Duckett D, Czerniecki B, Chen A, Smalley KSM, Forsyth PA. Law V, et al. Neuro Oncol. 2022 Oct 3;24(10):1673-1686. doi: 10.1093/neuonc/noac054. Neuro Oncol. 2022. PMID: 35213727 Free PMC article.
• Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease.

  Ballester LY, Glitza Oliva IC, Douse DY, Chen MM, Lan C, Haydu LE, Huse JT, Roy-Chowdhuri S, Luthra R, Wistuba II, Davies MA. Ballester LY, et al. J Neuropathol Exp Neurol. 2018 Jul 1;77(7):628-635. doi: 10.1093/jnen/nly046. J Neuropathol Exp Neurol. 2018. PMID: 29873738 Free PMC article.
• A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature.

  Fedorenko IV, Evernden B, Kenchappa RS, Sahebjam S, Ryzhova E, Puskas J, McIntosh L, Caceres G, Magliocco A, Etame A, Harbour JW, Smalley KS, Forsyth PA. Fedorenko IV, et al. Melanoma Res. 2016 Oct;26(5):481-6. doi: 10.1097/CMR.0000000000000274. Melanoma Res. 2016. PMID: 27285292 Free PMC article. Review.
• Cerebrospinal fluid immunocytochemical analysis and neuroimaging in the diagnosis of primary leptomeningeal melanoma. Case report.

  Tosaka M, Tamura M, Oriuchi N, Horikoshi M, Joshita T, Sugawara K, Kobayashi S, Kohga H, Yoshida T, Sasaki T. Tosaka M, et al. J Neurosurg. 2001 Mar;94(3):528-32. doi: 10.3171/jns.2001.94.3.0528. J Neurosurg. 2001. PMID: 11235962
• Primary pineal melanoma with leptomeningeal spreading: case report and review of the literature.

  Martin-Blondel G, Rousseau A, Boch AL, Cacoub P, Sène D. Martin-Blondel G, et al. Clin Neuropathol. 2009 Sep-Oct;28(5):387-94. Clin Neuropathol. 2009. PMID: 19788056 Review.